NCT05226910View on ClinicalTrials.gov

HEMI-STIM. tDCS and Intensive Therapies

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

July 30, 2022

Study Completion Date

October 1, 2022

Conditions
Infantile Hemiplegia
Interventions
DEVICE

tDCS and intensive therapies

This intervention will consist in the combination of tDCS with CIMT (30 hours) and then with BIT (3 hours and 45 minutes)

DEVICE

Sham and intensive therapies

This intervention will consist in the combination of sham tDCS with CIMT (30 hours) and then with BIT (3 hours and 45 minutes)

Trial Locations (1)

45071

University of Castilla-La Mancha, Toledo

All Listed Sponsors
lead

University of Castilla-La Mancha

OTHER

NCT05226910 - HEMI-STIM. tDCS and Intensive Therapies | Biotech Hunter | Biotech Hunter